These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3372705)

  • 1. Effects of alpha 2-receptor blockade in addition to tricyclic antidepressants in therapy-resistant depression.
    Schmauss M; Laakmann G; Dieterle D
    J Clin Psychopharmacol; 1988 Apr; 8(2):108-11. PubMed ID: 3372705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of refractory depression with combination reserpine and tricyclic antidepressant therapy.
    Amsterdam JD; Berwish N
    J Clin Psychopharmacol; 1987 Aug; 7(4):238-42. PubMed ID: 3305592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
    Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lithium carbonate augmentation in tricyclic antidepressant-resistant depression].
    Dorevitch A; Ginath Y
    Harefuah; 1991 Dec; 121(11):429-30. PubMed ID: 1786889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Add-on polytherapy with antidepressants and its significance in inpatients with major depression.
    Wada K; Yamada N; Hamamura T; Suzuki H; Nakano Y; Kuroda S
    Psychiatry Clin Neurosci; 1999 Oct; 53(5):557-62. PubMed ID: 10595679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined therapy with tricyclic and MAOI antidepressants in the treatment of resistant major depression].
    Rosan TA; Mesones HL; Brengio F
    Acta Psiquiatr Psicol Am Lat; 1994 Dec; 40(4):314-20. PubMed ID: 7484185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verapamil is not an antidepressant in patients resistant to tricyclic antidepressants.
    Adlersberg S; Toren P; Mester R; Rehavi M; Skolnick P; Weizman A
    Clin Neuropharmacol; 1994 Jun; 17(3):294-7. PubMed ID: 9316675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of tricyclic-induced jitteriness to a phenothiazine in two patients.
    Pohl R; Yeragani VK; Ortiz A; Rainey JM; Gershon S
    J Clin Psychiatry; 1986 Aug; 47(8):427. PubMed ID: 3733676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antidepressant response to tricyclics in major depressives is accelerated with adjunctive use of methylphenidate.
    Gwirtsman HE; Szuba MP; Toren L; Feist M
    Psychopharmacol Bull; 1994; 30(2):157-64. PubMed ID: 7831449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic study of yohimbine and its pharmacodynamic effects on salivary secretion in patients treated with tricyclic antidepressants.
    Bagheri H; Picault P; Schmitt L; Houin G; Berlan M; Montastruc JL
    Br J Clin Pharmacol; 1994 Jan; 37(1):93-6. PubMed ID: 8148228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological treatment of delusional depression].
    Amore M; Giordani L; Giorgetti G; Zazzeri N
    Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
    Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma tricyclic antidepressant concentrations in two patients concurrently treated with fluoxetine.
    Downs JM; Downs AD; Rosenthal TL; Deal N; Akiskal HS
    J Clin Psychiatry; 1989 Jun; 50(6):226-7. PubMed ID: 2785987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of tricyclic antidepressants on basal thyroid hormone levels in depressed patients.
    Joffe RT; Singer W
    Pharmacopsychiatry; 1990 Mar; 23(2):67-9. PubMed ID: 2339180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of generalized anxiety disorder in patients with depressive symptomatology.
    Rickels K; Schweizer E
    J Clin Psychiatry; 1993 Jan; 54 Suppl():20-3. PubMed ID: 8093885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and feasibility of high dose tricyclic antidepressant treatment in elderly delusional depressives.
    Brown RP; Kocsis JH; Glick ID; Dhar AK
    J Clin Psychopharmacol; 1984 Dec; 4(6):311-5. PubMed ID: 6511997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triazolam treatment of insomnia in depressed patients taking tricyclics.
    Cohn JB
    J Clin Psychiatry; 1983 Nov; 44(11):401-6. PubMed ID: 6139364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.